Human liver stem cells improve liver injury in a model of fulminant liver failure

Hepatology

Volumn 57, Issue 1, 2013, Pages 311-319

  Herrera, Maria Beatriz ^a,b   Fonsato, Valentina ^a   Bruno, Stefania ^a   Grange, Cristina ^a   Gilbo, Nicholas ^c   Romagnoli, Renato ^c   Tetta, Ciro ^d   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Sis Ter SpA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d FRESENIUS MEDICAL CARE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8; GALACTOSAMINE; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; SCATTER FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CHROMOSOME; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FULMINANT HEPATIC FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN LIVER STEM CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER BLOOD VESSEL; LIVER INJURY; LIVER PARENCHYMA; LIVER REGENERATION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; STEM CELL; SURVIVAL RATE;

ADULT STEM CELLS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CULTURE MEDIA, CONDITIONED; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; HUMANS; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE, ACUTE; LIVER REGENERATION; MALE; MICE; MICE, SCID; MULTIPOTENT STEM CELLS; NECROSIS;

EID: 84872167512     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25986     Document Type: Article

References (24)

1. Russo FP, Parola M. Stem and progenitor cells in liver regeneration and repair. Cytotherapy. 2011; 13: 135-144.
2. Kobayashi N, Okitsu T, Tanaka N. Cell choice for bioartificial livers. Keio J Med 2003; 52: 151-157.
3. Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008; 1782: 61-74.
4. Stock P, Brückner S, Ebensing S, Hempel M, Dollinger MM, Christ B. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc 2010; 5: 617-627.
5. Piryaei A, Valojerdi MR, Shahsavani M, Baharvand H. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Rev 2011; 7: 103-118.
6. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007; 2: e941.
7. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006; 24: 2840-2850.
8. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010; 14: 1605-1618.
9. Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, Tsuruyama T, et al. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One 2011; 296: e19195.
10. Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 165: 657-663.
11. Herrera MB, Bussolanti B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007; 72: 430-441.
12. Boddington SE, Sutton EJ, Henning TD, Nedopil AJ, Sennino B, Kim A, et al. Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact. Mol Imaging Biol 2011; 13: 3-9.
13. Sutton EJ, Boddington SE, Nedopil AJ, Henning TD, Demos SG, Baehner R, et al. An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis. Opt Express 2009; 17: 24403-24413.
14. Dhawan A, Puppi J, Hughes RD, Mitry RR. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010; 7: 288-298.
15. Cho KA, Lim GW, Joo SY, Woo SY, Seoh JY, Cho SJ, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Liver Int 2011; 31: 932-939.
16. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. HEPATOLOGY 2004; 40: 1304-1311.
17. Zagoura DS, Roubelakis MG, Bitsika V, Trohatou O, Pappa KI, Kapelouzou A, et al. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut 2012; 61: 894-906.
18. Strick-Marchand H, Masse GX, Weiss MC, Di Santo JP. Lymphocytes support oval cell-dependent liver regeneration. J Immunol 2008;18:2764-2771.
19. Van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. HEPATOLOGY 2008; 47: 1634-1643.
20. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009; 153: 347-358.
21. Tögel F, Zhang P, Hu Z, Westenfelder C. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 2009; 13: 2109-2114.
22. Martin D, Galisteo R, Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 2009; 284: 6038-6042.
23. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002; 27: 63-68.
24. Li WC, Ralphs KL, Tosh D. Isolation and culture of adult mouse hepatocytes. Methods Mol Biol 2010; 633: 185-196.